Kabataş, E. U. Et Al. 2017. Comparison of Intravitreal Bevacizumab, Intravitreal Ranibizumab and Laser Photocoagulation for Treatment of Type 1 Retinopathy of Prematurity in Turkish Preterm Children. Current Eye Research , vol.42, no.7 , 1054-1058.

Kabataş, E. U., Kurtul, B. E., Altıaylık Özer, P., & Kabataş, N., (2017). Comparison of Intravitreal Bevacizumab, Intravitreal Ranibizumab and Laser Photocoagulation for Treatment of Type 1 Retinopathy of Prematurity in Turkish Preterm Children. Current Eye Research , vol.42, no.7, 1054-1058.

Kabataş, Emrah Et Al. "Comparison of Intravitreal Bevacizumab, Intravitreal Ranibizumab and Laser Photocoagulation for Treatment of Type 1 Retinopathy of Prematurity in Turkish Preterm Children," Current Eye Research , vol.42, no.7, 1054-1058, 2017

Kabataş, Emrah U. Et Al. "Comparison of Intravitreal Bevacizumab, Intravitreal Ranibizumab and Laser Photocoagulation for Treatment of Type 1 Retinopathy of Prematurity in Turkish Preterm Children." Current Eye Research , vol.42, no.7, pp.1054-1058, 2017

Kabataş, E. U. Et Al. (2017) . "Comparison of Intravitreal Bevacizumab, Intravitreal Ranibizumab and Laser Photocoagulation for Treatment of Type 1 Retinopathy of Prematurity in Turkish Preterm Children." Current Eye Research , vol.42, no.7, pp.1054-1058.

@article{article, author={Emrah Utku Kabataş Et Al. }, title={Comparison of Intravitreal Bevacizumab, Intravitreal Ranibizumab and Laser Photocoagulation for Treatment of Type 1 Retinopathy of Prematurity in Turkish Preterm Children}, journal={Current Eye Research}, year=2017, pages={1054-1058} }